PARP1 and Parkinson disease: Since p53 and PARP1 hyperactivation has been implicated in neurodegeneration of PD [29,35], these DNA damage sensors might have contributed to PGC-1α repression, and mitochondrial dysfunction following telomere removal by CRISPR-Cas9.